Background: Hydrosalpinx significantly reduces the success rate of embryo implantation no dedicated occlusion currently exists for its treatment. This study introduces a novel shape-memory-based ...
The Medtronic Endurant stent graft system got FDA approval to remove a warning against use for ruptured abdominal aortic ...
Flaherty & Crumrine Preferred Income Opportunity Fund remains a buy, offering a 6.3% yield and trading at a 6.54% discount to NAV. PFO provides diversified exposure to preferred securities, with a ...
St. Luke's Health-Memorial Hospital Lufkin recently announced a significant advancement in cardiovascular care, becoming the first and only hospital in Deep East Texas to successfully perform a ...
Novel biodegradable patent foramen ovale (PFO) closure devices offer a promising therapeutic option. The efficacy and safety of the novel biodegradable devices compared with nitinol devices have not ...
Objective: Compare the efficacy and safety of biodegradable versus metallic occluders in the treatment of migraine patients with patent foramen ovale (PFO), and analyze the predictive factors for ...
US Patent and Trademark Office Director John Squires signaled an eagerness to encourage patenting AI innovations by striking down a tribunal’s line of reasoning he warned would render much of the ...
Medtronic added Penditure to its portfolio through the acquisition of Syntheon. The company launched the device in the U.S. shortly after inking the takeover. This week, Medtronic said it has sold ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback